MSSP

Community Medical Group

ACO Name and Location

CMG ACO, LLC
116 Washington Avenue, 3rd Floor
North Haven, CT 06473

ACO Primary Contact

Jennifer Cammarano
203.687.4422
jennifer.cammarano@priviahealth.com

Organizational Information

ACO Participants: ACO Participant in Joint Venture
Allergy & Pulmonary Specialists PC N
Anthony G Lendino, MD LLC N
Adam Bard, MD LLC N
Baginski Medical LLC N
Burton Rubin MD N
Caroline Lodato MD N
Chioma Nwokolo-Nwangwu MD N
Christopher Jakubowski MD LLC N
Collins Medical Associates 2 PC N
Connecticut Pulmonary Specialists PC N
Connecticut Medical Associates N
David J. Eilbott, MD PLLC N
Dean Har MD LLC N
Digestive Disease Associates LLC N
Doctors Office CT PLLC N
Eric Fan MD LLC N
Emily A Nolfo, MD LLC N
Endocrine Assoc of CT LLC N
Family Internal Medicine of Dixwell Avenue N
FPIM of New Haven County, LLC N
Fairfield Medical Group LLC N
Francis X. Walsh MD PC N
Gales Ferry Medical Group LLC N
Gandelman Cardiology PC N
Genesis Medical LLC N
Geriatric and Adult Psychiatry LLC N
Heritage Internal Medicine Associates LLC N
Heartcare Associates of Connecticut LLC N
Integrative Healthcare Associates LLC N
Internal Medicine of Guilford LLC N
Internal Medicine of Milford PC N
Internal Medicine of East Haven PC N
Jeffrey H Gimbel MD LLC N
James J. Zumpano MD LLC N
Kavita Joshi LLC N
Leonid Karkanista MD N
Livella Care LLC N
Lara A Colabelli, DO, PLLC N
M Marer MD N
Marcus Mayus MD Inc N
Med Care PC N
Monica Jain & Associates LLC N
Mark A Perrotti, MD LLC N
Melanie Kelton N
Mobile Care Solutions, PC N
New England Integrated Primary Care, Inc. N
Neurological Specialist, PC N
Old Greenwich Medical Group LLC  N
Orange Internal Medicine LLC N
Patient Choice Medical Care LLC N
Peter Licht MD & Jennifer Holloway MD LLC N
Primary Care of Shelton LLC N
Quinnipiac Medical of Branford LLC N
Rebecca Warkol MD LLC N
Si-Hoi Lam MD LLC N
Stanislaw Chorzepa MD N
Star Medical Care PLLC N
Sanjay Aggarwal MD N
Steven L. Saunders MC LLC N
Strong Women’s Health LLC N
Thompson Medical LLC N
Thrive Family Medicine N
Zadie Kenkare Internal Medicine PLLC NJ

 

ACO Governing Body:

Member
First Name
Member
Last Name
Member Title/Position Member’s Voting Power (Expressed as a percentage) Membership Type ACO Participant Legal Business Name, if applicable ACO Participant DBA, if applicable
Joseph Quaranta Chair 12.5% ACO Participant Quinnipiac Medical of Branford LLC None
Alan Siegal Voting Member 12.5% ACO Participant Geriatric and Adult Psychiatry LLC None
Adam Mayerson Voting Member 12.5% ACO Participant Endocrine Associates of CT LLC None
Paris Spanolios Voting Member 12.5% ACO Participant Internal Medicine of Milford PC None
Peter Cimino Voting Member 12.5% ACO Participant Fairfield Medical Group LLC None
James Rice Voting Member 12.5% Medicare Beneficiary NA None
Ronald Szabo Voting Member 12.5% ACO Participant Collins Medical Associates 2 PC None
Sharon Tan Voting Member 12.5% ACO Participant Collins Medical Associates 2 PC None

Member’s voting power may have been rounded to reflect a total voting power of 100 percent.

Key ACO Clinical and Administrative Leadership:

ACO Executive: Joseph L. Quaranta, MD

Medical Director: Joseph L. Quaranta, MD

Compliance Officer: Stephanie Clark

Quality Assurance/Improvement Officer: Sharon Wood, MSN, RN

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
Clinical Integration Committee Emily Nolfo, MD, Chair
Credentialing Committee Paris Spanolios, MD, Chair
Compensation Committee Joseph L. Quaranta, MD, Chair

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • Network of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • Fourth Agreement Period
    • Performance Year 2024, $6,684,150.87
  • Third Agreement Period
    • Performance Year 2022 $1,701,910.24
    • Performance Year 2023 $2,462,900.18
  • Second Agreement Period
    • Performance Year 2018, $0
    • Performance Year 2019 $ 2,765,174.94
    • Performance Year 2020 $5,883,996.83
    • Performance Year 2021 $2,957,059.71
  • First Agreement Period
    • Performance Year 2015 $0
    • Performance Year 2016 $0
    • Performance Year 2017 $0

Shared Savings Distribution:

  • Fourth Agreement Period
    • Performance Year 2024
    • Proportion invested in infrastructure: 25%
    • Proportion invested in redesigned care processes/resources: 45%
    • Proportion of distribution to ACO participants: 30%
  • Third Agreement Period
    • Performance Year 2022
    • Proportion invested in infrastructure: 25%
    • Proportion invested in redesigned care processes/resources: 45%
    • Proportion of distribution to ACO participants: 30%
    • Performance Year 2023
    • Proportion invested in infrastructure: 25%
    • Proportion invested in redesigned care processes/resources: 45%
    • Proportion of distribution to ACO participants: 30%
  • Second Agreement Period
    • Performance Year 2018
    • Proportion invested in infrastructure: NA
    • Proportion invested in redesigned care processes/resources: NA
    • Proportion of distribution to ACO participants: NA
    • Performance Year 2019
    • Proportion invested in infrastructure: 25%
    • Proportion invested in redesigned care processes/resources: 45%
    • Proportion of distribution to ACO participants: 30%
    • Performance Year 2020
    • Proportion invested in infrastructure: 25%
    • Proportion invested in redesigned care processes/resources: 45%
    • Proportion of distribution to ACO participants: 30%
    • Performance Year 2021
    • Proportion invested in infrastructure: 25%
    • Proportion invested in redesigned care processes/resources: 45%
    • Proportion of distribution to ACO participants: 30%
  • First Agreement Period
    • Performance Year 2015
    • Proportion invested in infrastructure: NA
    • Proportion invested in redesigned care processes/resources: NA
    • Proportion of distribution to ACO participants: NA
    • Performance Year 2016
    • Proportion invested in infrastructure: NA
    • Proportion invested in redesigned care processes/resources: NA
    • Proportion of distribution to ACO participants: NA
    • Performance Year 2017
    • Proportion invested in infrastructure: NA
    • Proportion invested in redesigned care processes/resources: NA
    • Proportion of distribution to ACO participants: NA

Quality Performance Results

2024 Quality Performance Results:

Quality performance results are based on the CMS Web Interface collection type.

Measure # Measure Title Collection Type Performance Rate*  Current Year Mean Performance Rate (Shared Savings Program ACOs)
Quality ID#: 001

 

Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)  [1]

 

CMS Web Interface 9.69

 

9.44

 

Quality ID#: 134

 

Preventive Care and Screening: Screening for Depression and Follow-up Plan

 

CMS Web Interface 76.89

 

81.46

 

Quality ID#: 236

 

Controlling High Blood Pressure

 

CMS Web Interface 82.23

 

79.49

 

Quality ID#: 318

 

Falls: Screening for Future Fall Risk

 

CMS Web Interface 94.43

 

88.99

 

Quality ID#: 110

 

Preventive Care and Screening: Influenza Immunization

 

CMS Web Interface 65.94

 

68.60

 

Quality ID#: 226

 

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

 

CMS Web Interface 73.33

 

79.98

 

Quality ID#: 113

 

Colorectal Cancer Screening

 

CMS Web Interface 82.35

 

77.81

 

Quality ID#: 112

 

Breast Cancer Screening

 

CMS Web Interface 81.82

 

80.93

 

Quality ID#: 438

 

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

 

CMS Web Interface 90.61

 

86.50

 

Quality ID#: 370

 

Depression Remission at Twelve Months

 

CMS Web Interface 24.39

 

17.35

 

Quality ID#: 321

 

CAHPS for MIPS [2]

 

CMS Web Interface 6.85

 

6.67

 

Measure # 479

 

Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [1]

 

CMS Web Interface 0.1550

 

0.1517

 

Measure # 484

 

Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions [1]

 

CMS Web Interface

 

37.00

 

Quality ID#: 001

 

Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [1]

 

eCQM/MIPS CQM 27.41

 

28.04

 

Quality ID#: 134

 

Preventive Care and Screening: Screening for Depression and Follow-up Plan

 

eCQM/MIPS CQM 48.40

 

63.04

 

Quality ID#: 236

 

Controlling High Blood Pressure

 

eCQM/MIPS CQM 74.02

 

66.78

 

Quality ID#: 321

 

CAHPS for MIPS [2]

 

eCQM/MIPS CQM 6.85

 

6.67

 

Measure # 479

 

Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [1]

 

eCQM/MIPS CQM 0.1550

 

 

0.1517

 

Measure # 484

 

Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions [1]

 

eCQM/MIPS CQM

 

37.00

 

*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.

*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

For previous years’ Financial and Quality Performance Results, please visit: Data.cms.gov